文献速递乳腺乳腺X线

乳腺X线摄影密度与乳腺癌分子亚型关联的系统综述与Meta分析

The association between mammographic density and breast cancer molecular subtypes: a systematic review and meta-analysis.
PubMed 文献 · Clin Radiol · 2023-05-06

该系统综述与Meta分析纳入23项研究共17193例乳腺癌病例,评估高乳腺X线摄影密度与各乳腺癌分子亚型的关联。病例对照/队列研究中最高密度类别与最低密度类别相比,三阴性、HER-2阳性、luminal A和luminal B乳腺癌风险分别升高2.24倍、1.81倍、1.44倍和1.59倍。病例仅研究显示BIRADS 4相比BIRADS 1,luminal A、luminal B和HER-2阳性 versus 三阴性的相对风险比分别为1.62、1.81和2.58。结论认为MD是多数乳腺癌亚型的强危险因素,与HER-2阳性癌关联更强。

要点

  • 病例对照/队列研究中最高密度类别较低密度类别三阴性癌风险升高2.24倍(95%CI 1.53-3.28)。
  • 病例仅研究中BIRADS 4较BIRADS 1的HER-2阳性 versus 三阴性相对风险比为2.58(95%CI 1.63-4.08)。
  • MD与HER-2阳性癌的关联强于其他乳腺癌亚型。

核心结论

  • 证据表明MD是多数乳腺癌亚型的强危险因素,但关联程度不同。
  • MD升高与HER-2阳性癌的关联较其他乳腺癌亚型更强。
  • 将MD作为亚型特异性风险标志物可能有助于建立个性化风险预测模型和筛查方案。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Cochrane Library和Embase数据库,检索时间为2022年10月。
  • 纳入23项研究共17193例乳腺癌病例,包括5项队列/病例对照研究和18项病例仅研究。
  • 病例对照研究采用随机/固定效应模型合并MD的相对风险(RR),病例仅研究采用相对风险比(RRR)比较luminal A、luminal B和HER-2阳性 versus 三阴性肿瘤。

诊断标准与关键数值

  • 病例对照/队列研究中,最高密度类别 versus 最低密度类别:三阴性癌RR 2.24(95%CI 1.53-3.28),HER-2阳性癌RR 1.81(95%CI 1.15-2.85),luminal A癌RR 1.44(95%CI 1.14-1.81),luminal B癌RR 1.59(95%CI 0.89-2.85)。
  • 病例仅研究中,BIRADS 4 versus BIRADS 1:luminal A versus 三阴性RRR 1.62(95%CI 1.14-2.31),luminal B versus 三阴性RRR 1.81(95%CI 1.22-2.71),HER-2阳性 versus 三阴性RRR 2.58(95%CI 1.63-4.08)。

临床应用与阅片要点

  • 原文结论指出,将MD作为亚型特异性风险标志物可能有助于建立个性化风险预测模型和筛查方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To conduct a systematic review and meta-analysis to evaluate the whether high mammographic density (MD) is differentially associated with all subtypes of breast cancer.

MATERIALS AND METHODS: The PubMed, Cochrane Library, and Embase databases were searched systematically in October 2022 to include all studies that investigated the association between MD and breast cancer subtype. Aggregate data of 17,193 breast cancer cases from 23 studies were selected, including five cohort/case-control and 18 case-only studies. The relative risk (RR) of MD were combined using random/fixed effects models for case-control studies, and for case-only studies, relative risk ratios (RRRs) were a combination of luminal A, luminal B, and HER2-positive versus triple-negative tumours.

RESULTS: Women in the highest density category in case-control/cohort studies had a 2.24-fold (95% confidence interval [CI] 1.53, 3.28), 1.81-fold (95% CI 1.15, 2.85), 1.44-fold (95% CI 1.14, 1.81), and 1.59-fold (95% CI 0.89, 2.85) higher risk of triple-negative, HER-2 (human epidermal growth factor receptor 2) positive, luminal A, and luminal B breast cancer compared to women in the lowest density category. RRRs for breast tumours being luminal A, luminal B, and HER-2 positive versus triple-negative in case-only studies were 1.62 (95% CI 1.14, 2.31), 1.81 (95% CI 1.22, 2.71) and 2.58 (95% CI 1.63, 4.08), respectively, for BIRADS 4 versus BIRADS 1.

CONCLUSION: The evidence indicates MD is a potent risk factor for the majority of breast cancer subtypes to different degrees. Increased MD is more strongly linked to HER-2-positive cancers compared to other breast cancer subtypes. The application of MD as a subtype-specific risk marker may facilitate the creation of personalised risk prediction models and screening procedures.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Bai, Song, Chen, et al. The association between mammographic density and breast cancer molecular subtypes: a systematic review and meta-analysis. Clin Radiol. 2023. PMID: 37230842. doi:10.1016/j.crad.2023.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。